Drug interactions for the following drug(s)
Applies to: mycophenolate mofetil 250 MG Oral Capsule <> Omeprazole 20 MG Delayed Release Oral Tablet
Omeprazole may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
Applies to: ZOLMitriptan 5 MG Oral Tablet <> insulin glargine 100 UNT/ML in 3 ML Pen Injector
The metabolism of Zolmitriptan can be increased when combined with Insulin glargine.
Applies to: mycophenolate mofetil 500 MG Oral Tablet <> Omeprazole 20 MG Delayed Release Oral Tablet
Omeprazole may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
Applies to: mycophenolate mofetil 500 MG Oral Tablet <> Prednisone 5 MG Oral Tablet
The risk or severity of adverse effects can be increased when Prednisone is combined with Mycophenolate mofetil.
Applies to: Tacrolimus 5 MG Oral Capsule <> mycophenolate mofetil 250 MG Oral Capsule
Tacrolimus may increase the immunosuppressive activities of Mycophenolate mofetil.
Applies to: Piroxicam 20 MG Oral Capsule <> Sertraline 50 MG Oral Tablet
The risk or severity of bleeding can be increased when Sertraline is combined with Piroxicam.
Applies to: pregabalin 75 MG Oral Capsule <> insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector
The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Insulin aspart.
Applies to: insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
The therapeutic efficacy of Insulin aspart can be increased when used in combination with Hydroxychloroquine.
Applies to: pregabalin 75 MG Oral Capsule <> insulin glargine 100 UNT/ML in 3 ML Pen Injector
The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Pregabalin.
Applies to: Tacrolimus 5 MG Oral Capsule <> Prochlorperazine 5 MG Oral Tablet
The metabolism of Tacrolimus can be decreased when combined with Prochlorperazine.
Applies to: ZOLMitriptan 5 MG Oral Tablet <> Omeprazole 20 MG Delayed Release Oral Tablet
The metabolism of Zolmitriptan can be decreased when combined with Omeprazole.
Applies to: mycophenolate mofetil 250 MG Oral Capsule <> pregabalin 75 MG Oral Capsule
Pregabalin may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
Applies to: insulin glargine 100 UNT/ML in 3 ML Pen Injector <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
The therapeutic efficacy of Insulin glargine can be increased when used in combination with Hydroxychloroquine.
Applies to: Prednisone 5 MG Oral Tablet <> pregabalin 75 MG Oral Capsule
Pregabalin may decrease the excretion rate of Prednisone which could result in a higher serum level.
Applies to: Tacrolimus 5 MG Oral Capsule <> pregabalin 75 MG Oral Capsule
The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Tacrolimus.
Applies to: ZOLMitriptan 5 MG Oral Tablet <> pregabalin 75 MG Oral Capsule
The therapeutic efficacy of Zolmitriptan can be increased when used in combination with Pregabalin.
Applies to: Sertraline 50 MG Oral Tablet <> pregabalin 75 MG Oral Capsule
The therapeutic efficacy of Sertraline can be increased when used in combination with Pregabalin.
Applies to: ZOLMitriptan 5 MG Oral Tablet <> Sertraline 50 MG Oral Tablet
The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Sertraline.
Applies to: Prochlorperazine 5 MG Oral Tablet <> pregabalin 75 MG Oral Capsule
The therapeutic efficacy of Prochlorperazine can be increased when used in combination with Pregabalin.
Applies to: Piroxicam 20 MG Oral Capsule <> pregabalin 75 MG Oral Capsule
Piroxicam may decrease the excretion rate of Pregabalin which could result in a higher serum level.
Applies to: mycophenolate mofetil 250 MG Oral Capsule <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Hydroxychloroquine.
Applies to: mycophenolate mofetil 500 MG Oral Tablet <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Hydroxychloroquine.
Applies to: Prochlorperazine 5 MG Oral Tablet <> Sertraline 50 MG Oral Tablet
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Sertraline.
Applies to: insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector <> insulin glargine 100 UNT/ML in 3 ML Pen Injector
The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin aspart.
Applies to: Piroxicam 20 MG Oral Capsule <> Omeprazole 20 MG Delayed Release Oral Tablet
The metabolism of Omeprazole can be decreased when combined with Piroxicam.
Applies to: pregabalin 75 MG Oral Capsule <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
The therapeutic efficacy of Hydroxychloroquine can be decreased when used in combination with Pregabalin.
Applies to: Piroxicam 20 MG Oral Capsule <> mycophenolate mofetil 250 MG Oral Capsule
Piroxicam may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
Applies to: Tacrolimus 5 MG Oral Capsule <> Prednisone 5 MG Oral Tablet
Tacrolimus may increase the immunosuppressive activities of Prednisone.
Applies to: ZOLMitriptan 5 MG Oral Tablet <> Prochlorperazine 5 MG Oral Tablet
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Prochlorperazine.
Applies to: Piroxicam 20 MG Oral Capsule <> mycophenolate mofetil 500 MG Oral Tablet
Piroxicam may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
Applies to: Tacrolimus 5 MG Oral Capsule <> Omeprazole 20 MG Delayed Release Oral Tablet
The metabolism of Tacrolimus can be decreased when combined with Omeprazole.
Applies to: Piroxicam 20 MG Oral Capsule <> Prednisone 5 MG Oral Tablet
The risk or severity of gastrointestinal irritation can be increased when Piroxicam is combined with Prednisone.
Applies to: Sertraline 50 MG Oral Tablet <> Omeprazole 20 MG Delayed Release Oral Tablet
The metabolism of Omeprazole can be decreased when combined with Sertraline.
Applies to: Prochlorperazine 5 MG Oral Tablet <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Prochlorperazine.
Applies to: Prochlorperazine 5 MG Oral Tablet <> Omeprazole 20 MG Delayed Release Oral Tablet
The metabolism of Prochlorperazine can be increased when combined with Omeprazole.
Applies to: Sertraline 50 MG Oral Tablet <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
The metabolism of Sertraline can be decreased when combined with Hydroxychloroquine.
Applies to: Sertraline 50 MG Oral Tablet <> insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector
The risk or severity of hypoglycemia can be increased when Sertraline is combined with Insulin aspart.
Applies to: Tacrolimus 5 MG Oral Capsule <> mycophenolate mofetil 500 MG Oral Tablet
Tacrolimus may increase the immunosuppressive activities of Mycophenolate mofetil.
Applies to: Tacrolimus 5 MG Oral Capsule <> insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector
The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Tacrolimus.
Applies to: Tacrolimus 5 MG Oral Capsule <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
Tacrolimus may increase the immunosuppressive activities of Hydroxychloroquine.
Applies to: Tacrolimus 5 MG Oral Capsule <> insulin glargine 100 UNT/ML in 3 ML Pen Injector
The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Tacrolimus.
Applies to: mycophenolate mofetil 250 MG Oral Capsule <> Prednisone 5 MG Oral Tablet
The risk or severity of adverse effects can be increased when Prednisone is combined with Mycophenolate mofetil.
Applies to: Sertraline 50 MG Oral Tablet <> insulin glargine 100 UNT/ML in 3 ML Pen Injector
The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Sertraline.
Applies to: Piroxicam 20 MG Oral Capsule <> Tacrolimus 5 MG Oral Capsule
The risk or severity of renal failure can be increased when Piroxicam is combined with Tacrolimus.
Applies to: Prednisone 5 MG Oral Tablet <> insulin glargine 100 UNT/ML in 3 ML Pen Injector
The risk or severity of hyperglycemia can be increased when Prednisone is combined with Insulin glargine.
Applies to: mycophenolate mofetil 500 MG Oral Tablet <> pregabalin 75 MG Oral Capsule
Pregabalin may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
Applies to: Piroxicam 20 MG Oral Capsule <> ZOLMitriptan 5 MG Oral Tablet
The risk or severity of hypertension can be increased when Zolmitriptan is combined with Piroxicam.
Applies to: Prednisone 5 MG Oral Tablet <> insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector
The risk or severity of hyperglycemia can be increased when Prednisone is combined with Insulin aspart.
Applies to: Prednisone 5 MG Oral Tablet <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
The risk or severity of adverse effects can be increased when Prednisone is combined with Hydroxychloroquine.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: mycophenolate mofetil 250 MG Oral Capsule <> Omeprazole 20 MG Delayed Release Oral Tablet
Drug1 (rxcui = 199058, name = mycophenolate mofetil 250 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Omeprazole and Mycophenolate mofetil.
Applies to: ZOLMitriptan 5 MG Oral Tablet <> insulin glargine 100 UNT/ML in 3 ML Pen Injector
Drug1 (rxcui = 200194, name = zolmitriptan 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 847230, name = 3 ML insulin glargine 100 UNT/ML Pen Injector, tty = SCD). Drug1 is resolved to zolmitriptan, Drug2 is resolved to insulin glargine and interaction asserted in DrugBank between Zolmitriptan and Insulin glargine.
Applies to: mycophenolate mofetil 500 MG Oral Tablet <> Omeprazole 20 MG Delayed Release Oral Tablet
Drug1 (rxcui = 200060, name = mycophenolate mofetil 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Omeprazole and Mycophenolate mofetil.
Applies to: mycophenolate mofetil 500 MG Oral Tablet <> Prednisone 5 MG Oral Tablet
Drug1 (rxcui = 200060, name = mycophenolate mofetil 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 312617, name = prednisone 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to prednisone, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Prednisone and Mycophenolate mofetil.
Applies to: Tacrolimus 5 MG Oral Capsule <> mycophenolate mofetil 250 MG Oral Capsule
Drug1 (rxcui = 198378, name = tacrolimus 5 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 199058, name = mycophenolate mofetil 250 MG Oral Capsule, tty = SCD). Drug1 is resolved to tacrolimus, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Tacrolimus and Mycophenolate mofetil. Drug1 is resolved to mycophenolate mofetil, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Mycophenolate mofetil and Tacrolimus.
Applies to: Piroxicam 20 MG Oral Capsule <> Sertraline 50 MG Oral Tablet
Drug1 (rxcui = 198108, name = piroxicam 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 312941, name = sertraline 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to piroxicam, Drug2 is resolved to sertraline and interaction asserted in DrugBank between Piroxicam and Sertraline. Drug1 is resolved to sertraline, Drug2 is resolved to piroxicam-beta-cyclodextrin and interaction asserted in DrugBank between Sertraline and Piroxicam.
Applies to: pregabalin 75 MG Oral Capsule <> insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector
Drug1 (rxcui = 483450, name = pregabalin 75 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 847191, name = 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector, tty = SCD). Drug1 is resolved to insulin aspart, human, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Insulin aspart and Pregabalin. Drug1 is resolved to pregabalin, Drug2 is resolved to insulin aspart protamine, human and interaction asserted in DrugBank between Pregabalin and Insulin aspart.
Applies to: insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
Drug1 (rxcui = 847191, name = 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector, tty = SCD). Drug2 (rxcui = 979092, name = hydroxychloroquine sulfate 200 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to insulin aspart, human and interaction asserted in DrugBank between Hydroxychloroquine and Insulin aspart. Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to insulin aspart protamine, human and interaction asserted in DrugBank between Hydroxychloroquine and Insulin aspart.
Applies to: pregabalin 75 MG Oral Capsule <> insulin glargine 100 UNT/ML in 3 ML Pen Injector
Drug1 (rxcui = 483450, name = pregabalin 75 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 847230, name = 3 ML insulin glargine 100 UNT/ML Pen Injector, tty = SCD). Drug1 is resolved to pregabalin, Drug2 is resolved to insulin glargine and interaction asserted in DrugBank between Pregabalin and Insulin glargine.
Applies to: Tacrolimus 5 MG Oral Capsule <> Prochlorperazine 5 MG Oral Tablet
Drug1 (rxcui = 198378, name = tacrolimus 5 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 312635, name = prochlorperazine 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to prochlorperazine, Drug2 is resolved to tacrolimus and interaction asserted in DrugBank between Prochlorperazine and Tacrolimus. Drug1 is resolved to prochlorperazine, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Prochlorperazine and Tacrolimus.
Applies to: ZOLMitriptan 5 MG Oral Tablet <> Omeprazole 20 MG Delayed Release Oral Tablet
Drug1 (rxcui = 200194, name = zolmitriptan 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to zolmitriptan and interaction asserted in DrugBank between Omeprazole and Zolmitriptan.
Applies to: mycophenolate mofetil 250 MG Oral Capsule <> pregabalin 75 MG Oral Capsule
Drug1 (rxcui = 199058, name = mycophenolate mofetil 250 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 483450, name = pregabalin 75 MG Oral Capsule, tty = SCD). Drug1 is resolved to mycophenolate mofetil, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Mycophenolate mofetil and Pregabalin.
Applies to: insulin glargine 100 UNT/ML in 3 ML Pen Injector <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
Drug1 (rxcui = 847230, name = 3 ML insulin glargine 100 UNT/ML Pen Injector, tty = SCD). Drug2 (rxcui = 979092, name = hydroxychloroquine sulfate 200 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to insulin glargine and interaction asserted in DrugBank between Hydroxychloroquine and Insulin glargine.
Applies to: Prednisone 5 MG Oral Tablet <> pregabalin 75 MG Oral Capsule
Drug1 (rxcui = 312617, name = prednisone 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 483450, name = pregabalin 75 MG Oral Capsule, tty = SCD). Drug1 is resolved to prednisone, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Prednisone and Pregabalin.
Applies to: Tacrolimus 5 MG Oral Capsule <> pregabalin 75 MG Oral Capsule
Drug1 (rxcui = 198378, name = tacrolimus 5 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 483450, name = pregabalin 75 MG Oral Capsule, tty = SCD). Drug1 is resolved to pregabalin, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Pregabalin and Tacrolimus. Drug1 is resolved to tacrolimus, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Tacrolimus and Pregabalin.
Applies to: ZOLMitriptan 5 MG Oral Tablet <> pregabalin 75 MG Oral Capsule
Drug1 (rxcui = 200194, name = zolmitriptan 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 483450, name = pregabalin 75 MG Oral Capsule, tty = SCD). Drug1 is resolved to zolmitriptan, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Zolmitriptan and Pregabalin.
Applies to: Sertraline 50 MG Oral Tablet <> pregabalin 75 MG Oral Capsule
Drug1 (rxcui = 312941, name = sertraline 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 483450, name = pregabalin 75 MG Oral Capsule, tty = SCD). Drug1 is resolved to sertraline, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Sertraline and Pregabalin.
Applies to: ZOLMitriptan 5 MG Oral Tablet <> Sertraline 50 MG Oral Tablet
Drug1 (rxcui = 200194, name = zolmitriptan 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 312941, name = sertraline 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to sertraline, Drug2 is resolved to zolmitriptan and interaction asserted in DrugBank between Sertraline and Zolmitriptan.
Applies to: Prochlorperazine 5 MG Oral Tablet <> pregabalin 75 MG Oral Capsule
Drug1 (rxcui = 312635, name = prochlorperazine 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 483450, name = pregabalin 75 MG Oral Capsule, tty = SCD). Drug1 is resolved to prochlorperazine, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Prochlorperazine and Pregabalin.
Applies to: Piroxicam 20 MG Oral Capsule <> pregabalin 75 MG Oral Capsule
Drug1 (rxcui = 198108, name = piroxicam 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 483450, name = pregabalin 75 MG Oral Capsule, tty = SCD). Drug1 is resolved to piroxicam-beta-cyclodextrin, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Piroxicam and Pregabalin. Drug1 is resolved to piroxicam, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Piroxicam and Pregabalin.
Applies to: mycophenolate mofetil 250 MG Oral Capsule <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
Drug1 (rxcui = 199058, name = mycophenolate mofetil 250 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 979092, name = hydroxychloroquine sulfate 200 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Hydroxychloroquine and Mycophenolate mofetil.
Applies to: mycophenolate mofetil 500 MG Oral Tablet <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
Drug1 (rxcui = 200060, name = mycophenolate mofetil 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 979092, name = hydroxychloroquine sulfate 200 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Hydroxychloroquine and Mycophenolate mofetil.
Applies to: Prochlorperazine 5 MG Oral Tablet <> Sertraline 50 MG Oral Tablet
Drug1 (rxcui = 312635, name = prochlorperazine 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 312941, name = sertraline 50 MG Oral Tablet, tty = SCD). Drug1 is resolved to prochlorperazine, Drug2 is resolved to sertraline and interaction asserted in DrugBank between Prochlorperazine and Sertraline.
Applies to: insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector <> insulin glargine 100 UNT/ML in 3 ML Pen Injector
Drug1 (rxcui = 847191, name = 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector, tty = SCD). Drug2 (rxcui = 847230, name = 3 ML insulin glargine 100 UNT/ML Pen Injector, tty = SCD). Drug1 is resolved to insulin glargine, Drug2 is resolved to insulin aspart protamine, human and interaction asserted in DrugBank between Insulin glargine and Insulin aspart. Drug1 is resolved to insulin aspart, human, Drug2 is resolved to insulin glargine and interaction asserted in DrugBank between Insulin aspart and Insulin glargine.
Applies to: Piroxicam 20 MG Oral Capsule <> Omeprazole 20 MG Delayed Release Oral Tablet
Drug1 (rxcui = 198108, name = piroxicam 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to piroxicam-beta-cyclodextrin and interaction asserted in DrugBank between Omeprazole and Piroxicam. Drug1 is resolved to omeprazole, Drug2 is resolved to piroxicam and interaction asserted in DrugBank between Omeprazole and Piroxicam.
Applies to: pregabalin 75 MG Oral Capsule <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
Drug1 (rxcui = 483450, name = pregabalin 75 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 979092, name = hydroxychloroquine sulfate 200 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Hydroxychloroquine and Pregabalin.
Applies to: Piroxicam 20 MG Oral Capsule <> mycophenolate mofetil 250 MG Oral Capsule
Drug1 (rxcui = 198108, name = piroxicam 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 199058, name = mycophenolate mofetil 250 MG Oral Capsule, tty = SCD). Drug1 is resolved to piroxicam-beta-cyclodextrin, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Piroxicam and Mycophenolate mofetil. Drug1 is resolved to piroxicam, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Piroxicam and Mycophenolate mofetil.
Applies to: Tacrolimus 5 MG Oral Capsule <> Prednisone 5 MG Oral Tablet
Drug1 (rxcui = 198378, name = tacrolimus 5 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 312617, name = prednisone 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to prednisone, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Prednisone and Tacrolimus. Drug1 is resolved to prednisone, Drug2 is resolved to tacrolimus and interaction asserted in DrugBank between Prednisone and Tacrolimus.
Applies to: ZOLMitriptan 5 MG Oral Tablet <> Prochlorperazine 5 MG Oral Tablet
Drug1 (rxcui = 200194, name = zolmitriptan 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 312635, name = prochlorperazine 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to prochlorperazine, Drug2 is resolved to zolmitriptan and interaction asserted in DrugBank between Prochlorperazine and Zolmitriptan.
Applies to: Piroxicam 20 MG Oral Capsule <> mycophenolate mofetil 500 MG Oral Tablet
Drug1 (rxcui = 198108, name = piroxicam 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 200060, name = mycophenolate mofetil 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to piroxicam-beta-cyclodextrin, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Piroxicam and Mycophenolate mofetil. Drug1 is resolved to piroxicam, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Piroxicam and Mycophenolate mofetil.
Applies to: Tacrolimus 5 MG Oral Capsule <> Omeprazole 20 MG Delayed Release Oral Tablet
Drug1 (rxcui = 198378, name = tacrolimus 5 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Omeprazole and Tacrolimus. Drug1 is resolved to omeprazole, Drug2 is resolved to tacrolimus and interaction asserted in DrugBank between Omeprazole and Tacrolimus.
Applies to: Piroxicam 20 MG Oral Capsule <> Prednisone 5 MG Oral Tablet
Drug1 (rxcui = 198108, name = piroxicam 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 312617, name = prednisone 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to prednisone, Drug2 is resolved to piroxicam-beta-cyclodextrin and interaction asserted in DrugBank between Prednisone and Piroxicam. Drug1 is resolved to piroxicam, Drug2 is resolved to prednisone and interaction asserted in DrugBank between Piroxicam and Prednisone.
Applies to: Sertraline 50 MG Oral Tablet <> Omeprazole 20 MG Delayed Release Oral Tablet
Drug1 (rxcui = 312941, name = sertraline 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to sertraline and interaction asserted in DrugBank between Omeprazole and Sertraline.
Applies to: Prochlorperazine 5 MG Oral Tablet <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
Drug1 (rxcui = 312635, name = prochlorperazine 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 979092, name = hydroxychloroquine sulfate 200 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to prochlorperazine and interaction asserted in DrugBank between Hydroxychloroquine and Prochlorperazine.
Applies to: Prochlorperazine 5 MG Oral Tablet <> Omeprazole 20 MG Delayed Release Oral Tablet
Drug1 (rxcui = 312635, name = prochlorperazine 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to prochlorperazine and interaction asserted in DrugBank between Omeprazole and Prochlorperazine.
Applies to: Sertraline 50 MG Oral Tablet <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
Drug1 (rxcui = 312941, name = sertraline 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 979092, name = hydroxychloroquine sulfate 200 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to sertraline and interaction asserted in DrugBank between Hydroxychloroquine and Sertraline.
Applies to: Sertraline 50 MG Oral Tablet <> insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector
Drug1 (rxcui = 312941, name = sertraline 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 847191, name = 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector, tty = SCD). Drug1 is resolved to sertraline, Drug2 is resolved to insulin aspart protamine, human and interaction asserted in DrugBank between Sertraline and Insulin aspart. Drug1 is resolved to sertraline, Drug2 is resolved to insulin aspart, human and interaction asserted in DrugBank between Sertraline and Insulin aspart.
Applies to: Tacrolimus 5 MG Oral Capsule <> mycophenolate mofetil 500 MG Oral Tablet
Drug1 (rxcui = 198378, name = tacrolimus 5 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 200060, name = mycophenolate mofetil 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to tacrolimus, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Tacrolimus and Mycophenolate mofetil. Drug1 is resolved to mycophenolate mofetil, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Mycophenolate mofetil and Tacrolimus.
Applies to: Tacrolimus 5 MG Oral Capsule <> insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector
Drug1 (rxcui = 198378, name = tacrolimus 5 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 847191, name = 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector, tty = SCD). Drug1 is resolved to tacrolimus, Drug2 is resolved to insulin aspart, human and interaction asserted in DrugBank between Tacrolimus and Insulin aspart. Drug1 is resolved to insulin aspart, human, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Insulin aspart and Tacrolimus. Drug1 is resolved to tacrolimus, Drug2 is resolved to insulin aspart protamine, human and interaction asserted in DrugBank between Tacrolimus and Insulin aspart. Drug1 is resolved to anhydrous tacrolimus, Drug2 is resolved to insulin aspart protamine, human and interaction asserted in DrugBank between Tacrolimus and Insulin aspart.
Applies to: Tacrolimus 5 MG Oral Capsule <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
Drug1 (rxcui = 198378, name = tacrolimus 5 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 979092, name = hydroxychloroquine sulfate 200 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Hydroxychloroquine and Tacrolimus. Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to tacrolimus and interaction asserted in DrugBank between Hydroxychloroquine and Tacrolimus.
Applies to: Tacrolimus 5 MG Oral Capsule <> insulin glargine 100 UNT/ML in 3 ML Pen Injector
Drug1 (rxcui = 198378, name = tacrolimus 5 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 847230, name = 3 ML insulin glargine 100 UNT/ML Pen Injector, tty = SCD). Drug1 is resolved to tacrolimus, Drug2 is resolved to insulin glargine and interaction asserted in DrugBank between Tacrolimus and Insulin glargine. Drug1 is resolved to anhydrous tacrolimus, Drug2 is resolved to insulin glargine and interaction asserted in DrugBank between Tacrolimus and Insulin glargine.
Applies to: mycophenolate mofetil 250 MG Oral Capsule <> Prednisone 5 MG Oral Tablet
Drug1 (rxcui = 199058, name = mycophenolate mofetil 250 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 312617, name = prednisone 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to prednisone, Drug2 is resolved to mycophenolate mofetil and interaction asserted in DrugBank between Prednisone and Mycophenolate mofetil.
Applies to: Sertraline 50 MG Oral Tablet <> insulin glargine 100 UNT/ML in 3 ML Pen Injector
Drug1 (rxcui = 312941, name = sertraline 50 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 847230, name = 3 ML insulin glargine 100 UNT/ML Pen Injector, tty = SCD). Drug1 is resolved to sertraline, Drug2 is resolved to insulin glargine and interaction asserted in DrugBank between Sertraline and Insulin glargine.
Applies to: Piroxicam 20 MG Oral Capsule <> Tacrolimus 5 MG Oral Capsule
Drug1 (rxcui = 198108, name = piroxicam 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 198378, name = tacrolimus 5 MG Oral Capsule, tty = SCD). Drug1 is resolved to piroxicam, Drug2 is resolved to tacrolimus and interaction asserted in DrugBank between Piroxicam and Tacrolimus. Drug1 is resolved to piroxicam, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Piroxicam and Tacrolimus. Drug1 is resolved to piroxicam-beta-cyclodextrin, Drug2 is resolved to anhydrous tacrolimus and interaction asserted in DrugBank between Piroxicam and Tacrolimus. Drug1 is resolved to tacrolimus, Drug2 is resolved to piroxicam-beta-cyclodextrin and interaction asserted in DrugBank between Tacrolimus and Piroxicam.
Applies to: Prednisone 5 MG Oral Tablet <> insulin glargine 100 UNT/ML in 3 ML Pen Injector
Drug1 (rxcui = 312617, name = prednisone 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 847230, name = 3 ML insulin glargine 100 UNT/ML Pen Injector, tty = SCD). Drug1 is resolved to prednisone, Drug2 is resolved to insulin glargine and interaction asserted in DrugBank between Prednisone and Insulin glargine.
Applies to: mycophenolate mofetil 500 MG Oral Tablet <> pregabalin 75 MG Oral Capsule
Drug1 (rxcui = 200060, name = mycophenolate mofetil 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 483450, name = pregabalin 75 MG Oral Capsule, tty = SCD). Drug1 is resolved to mycophenolate mofetil, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Mycophenolate mofetil and Pregabalin.
Applies to: Piroxicam 20 MG Oral Capsule <> ZOLMitriptan 5 MG Oral Tablet
Drug1 (rxcui = 198108, name = piroxicam 20 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 200194, name = zolmitriptan 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to piroxicam, Drug2 is resolved to zolmitriptan and interaction asserted in DrugBank between Piroxicam and Zolmitriptan. Drug1 is resolved to piroxicam-beta-cyclodextrin, Drug2 is resolved to zolmitriptan and interaction asserted in DrugBank between Piroxicam and Zolmitriptan.
Applies to: Prednisone 5 MG Oral Tablet <> insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector
Drug1 (rxcui = 312617, name = prednisone 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 847191, name = 3 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen Injector, tty = SCD). Drug1 is resolved to prednisone, Drug2 is resolved to insulin aspart protamine, human and interaction asserted in DrugBank between Prednisone and Insulin aspart. Drug1 is resolved to prednisone, Drug2 is resolved to insulin aspart, human and interaction asserted in DrugBank between Prednisone and Insulin aspart.
Applies to: Prednisone 5 MG Oral Tablet <> Hydroxychloroquine Sulfate 200 MG Oral Tablet
Drug1 (rxcui = 312617, name = prednisone 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 979092, name = hydroxychloroquine sulfate 200 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to prednisone and interaction asserted in DrugBank between Hydroxychloroquine and Prednisone.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.